Literature DB >> 30791487

FBXW7 in Cancer: What Has Been Unraveled Thus Far?

Bethsebie Lalduhsaki Sailo1, Kishore Banik2, Sosmitha Girisa3, Devivasha Bordoloi4, Lu Fan5, Clarissa Esmeralda Halim6, Hong Wang7, Alan Prem Kumar8,9,10,11, Dali Zheng12, Xinliang Mao13,14, Gautam Sethi15, Ajaikumar Bahulayan Kunnumakkara16.   

Abstract

: The FBXW7 (F-box with 7 tandem WD40) protein encoded by the gene FBXW7 is one of the crucial components of ubiquitin ligase called Skp1-Cullin1-F-box (SCF) complex that aids in the degradation of many oncoproteins via the ubiquitin-proteasome system (UPS) thus regulating cellular growth. FBXW7 is considered as a potent tumor suppressor as most of its target substrates can function as potential growth promoters, including c-Myc, Notch, cyclin E, c-JUN, and KLF5. Its regulators include p53, C/EBP-δ, Numb, microRNAs, Pin 1, Hes-5, BMI1, Ebp2. Mounting evidence has indicated the involvement of aberrant expression of FBXW7 for tumorigenesis. Moreover, numerous studies have also shown its role in cancer cell chemosensitization, thereby demonstrating the importance of FBXW7 in the development of curative cancer therapy. This comprehensive review emphasizes on the targets, functions, regulators and expression of FBXW7 in different cancers and its involvement in sensitizing cancer cells to chemotherapeutic drugs.

Entities:  

Keywords:  FBXW7; SCF complex; cancer; chemoresistance; chemosensitization; mutations; tumor suppressor

Year:  2019        PMID: 30791487      PMCID: PMC6406609          DOI: 10.3390/cancers11020246

Source DB:  PubMed          Journal:  Cancers (Basel)        ISSN: 2072-6694            Impact factor:   6.639


  46 in total

Review 1.  The vital role of ATP citrate lyase in chronic diseases.

Authors:  Amrita Devi Khwairakpam; Kishore Banik; Sosmitha Girisa; Bano Shabnam; Mehdi Shakibaei; Lu Fan; Frank Arfuso; Javadi Monisha; Hong Wang; Xinliang Mao; Gautam Sethi; Ajaikumar B Kunnumakkara
Journal:  J Mol Med (Berl)       Date:  2019-12-19       Impact factor: 4.599

2.  Merkel Cell Polyomavirus Small Tumor Antigen Activates Matrix Metallopeptidase-9 Gene Expression for Cell Migration and Invasion.

Authors:  Nnenna Nwogu; Luz E Ortiz; Adrian Whitehouse; Hyun Jin Kwun
Journal:  J Virol       Date:  2020-09-15       Impact factor: 5.103

3.  Genomic Aberrations in Circulating Tumor DNAs from Palbociclib-Treated Metastatic Breast Cancer Patients Reveal a Novel Resistance Mechanism.

Authors:  Maysa Abu-Khalaf; Chun Wang; Zhenchao Zhang; Rui Luo; Weelic Chong; Daniel P Silver; Frederick Fellin; Rebecca Jaslow; AnaMaria Lopez; Terrence Cescon; Wei Jiang; Ronald Myers; Qiang Wei; Bingshan Li; Massimo Cristofanilli; Hushan Yang
Journal:  Cancers (Basel)       Date:  2022-06-10       Impact factor: 6.575

4.  Genome and transcriptome profiling of FBXW family in human prostate cancer.

Authors:  Ruoxin Lan; Ben Jin; Yao-Zhong Liu; Kun Zhang; Tianhua Niu; Zongbing You
Journal:  Am J Clin Exp Urol       Date:  2020-08-15

Review 5.  The Role of Cullin-RING Ligases in Striated Muscle Development, Function, and Disease.

Authors:  Jordan Blondelle; Andrea Biju; Stephan Lange
Journal:  Int J Mol Sci       Date:  2020-10-26       Impact factor: 5.923

6.  Honokiol antagonizes doxorubicin resistance in human breast cancer via miR-188-5p/FBXW7/c-Myc pathway.

Authors:  Xianglan Yi; Liping Lou; Jun Wang; Jing Xiong; Sheng Zhou
Journal:  Cancer Chemother Pharmacol       Date:  2021-02-05       Impact factor: 3.333

Review 7.  Targeting Notch in oncology: the path forward.

Authors:  Samarpan Majumder; Judy S Crabtree; Todd E Golde; Lisa M Minter; Barbara A Osborne; Lucio Miele
Journal:  Nat Rev Drug Discov       Date:  2020-12-08       Impact factor: 84.694

8.  Attenuating glucose metabolism by Fbxw7 promotes Taxol sensitivity of colon cancer cells through downregulating NADPH oxidase 1 (Nox1).

Authors:  Hui-Peng Wang; Wen-Jie Chen; Jia-Men Shen; Tao Ye; Hong-Wei Xie
Journal:  Ann Transl Med       Date:  2021-05

Review 9.  The FBXW7-NOTCH interactome: A ubiquitin proteasomal system-induced crosstalk modulating oncogenic transformation in human tissues.

Authors:  Rohan Kar; Saurabh Kumar Jha; Shreesh Ojha; Ankur Sharma; Sunny Dholpuria; Venkata Sita Rama Raju; Parteek Prasher; Dinesh Kumar Chellappan; Gaurav Gupta; Sachin Kumar Singh; Keshav Raj Paudel; Philip M Hansbro; Sandeep Kumar Singh; Janne Ruokolainen; Kavindra Kumar Kesari; Kamal Dua; Niraj Kumar Jha
Journal:  Cancer Rep (Hoboken)       Date:  2021-04-06

10.  Exosomal transfer of miR‑25‑3p promotes the proliferation and temozolomide resistance of glioblastoma cells by targeting FBXW7.

Authors:  Jianxin Wang; Tianxiao Li; Bin Wang
Journal:  Int J Oncol       Date:  2021-07-19       Impact factor: 5.650

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.